Request Demo
Last update 27 Feb 2026
Bone marrow-derived mesenchymal stromal cells(The University of Queensland)
Last update 27 Feb 2026
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms bone marrow-derived mesenchymal stromal cells(The University of Queensland), Bone-marrow derived MSCs(The University of Queensland) |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Bone marrow-derived mesenchymal stromal cells(The University of Queensland)NCT02709343
Phase 2 Randomised Controlled Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (CLAD)
NCT01957826
Phase I/II Randomized Clinical Trial to Assess the Safety and Feasibility of Transendocardial Injection of Bone Marrow Autologous Mesenchymal Stem Cells in Patients With Idiopathic Dilated Cardiomyopathy.
100 Clinical Results associated with Bone marrow-derived mesenchymal stromal cells(The University of Queensland)
Login to view more data
100 Translational Medicine associated with Bone marrow-derived mesenchymal stromal cells(The University of Queensland)
Login to view more data
100 Patents (Medical) associated with Bone marrow-derived mesenchymal stromal cells(The University of Queensland)
Login to view more data
100 Deals associated with Bone marrow-derived mesenchymal stromal cells(The University of Queensland)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Allograft Rejection | Phase 2 | Australia | 21 Apr 2017 | |
| Coronary Artery Disease | Phase 2 | Spain | 31 Mar 2013 | |
| Idiopathic cardiomyopathy | Phase 2 | Spain | 31 Mar 2013 | |
| Cardiomyopathy, Dilated | Phase 2 | Spain | 01 Mar 2013 | |
| Liver Cirrhosis, Alcoholic | Phase 1 | United States | 20 Jun 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
HOVON-113 (EHA2022) Manual  | Phase 3 | 41 | Mesenchymal stromal cell | yvoxzmgwmg(luxeqyobpx) = nygnielwbm wicvfggccr (juliovlslf ) View more | Negative | 12 May 2022 | |
placebo | yvoxzmgwmg(luxeqyobpx) = xgahehmsim wicvfggccr (juliovlslf ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free